Feasibility Study of Tolerogenic Fibroblasts in Patients With Refractory Multiple Sclerosis
Clinical trial NCT05080270 · COMPLETED
Trial details
- NCT number
- NCT05080270
- Sponsor
- FibroBiologics
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-21
- Primary completion
- 2021-06-08
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.